Richard Klausner, Director at Juno Therapeutics, Inc. (JUNO), sold 8,000 shares at $50.00 ($400K) on 2015-10-15, disclosed to the SEC on 2015-10-16.
Scheduled sale ($400k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| LYEL | SELL | 2022-09-27 | $71K | — | Filing → |
| JUNO | SELL | 2018-01-09 | $1.2M | — | Filing → |
| JUNO | SELL | 2017-12-22 | $3.2M | — | Filing → |